History of allergic reaction or clinically significant intolerance to acetaminophen, aspirin, or any NSAIDs, including meloxicam

Requires continuous use of opioid or opioid combination products to control OA pain of the knee or hip

Clinically significant unstable cardiac, respiratory, neurological, immunological, hematological, or renal disease

Significant difficulties swallowing capsules or unable to tolerate oral medication

Has received any investigational drug (except Meloxicam SoluMatrix Capsules), device, or therapy within 30 days before Screening

Study of Meloxicam Capsules in Subjects With Osteoarthritis of the Knee or Hip